<DOC>
	<DOC>NCT00545844</DOC>
	<brief_summary>Effectiveness of adding montelukast to inhaled corticosteroids in adult subjects with both uncontrolled asthma and allergic rhinitis.</brief_summary>
	<brief_title>Singulair(R) In Asthma And Allergic Rhinitis (0476-383)</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Patient is a user of Inhaled Corticosteroid (ICS) or ICS/LongActing Beta 2Agonist (ICS/LABA) at any dosage Peak expiratory flow is &gt; or = 80% of predicted value on the day of visit 1 Uncontrolled as per Canadian asthma consensus guidelines Unwilling to stop regular use of histamine H1 antagonists for allergic rhinitis symptoms Unwilling to stop use of antihistamine eye drops or cromoglycate eye drops or ophthalmic corticosteroid</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>